Page last updated: 2024-10-22

albuterol and Oligohydramnios

albuterol has been researched along with Oligohydramnios in 1 studies

Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).

Oligohydramnios: A condition of abnormally low AMNIOTIC FLUID volume. Principal causes include malformations of fetal URINARY TRACT; FETAL GROWTH RETARDATION; GESTATIONAL HYPERTENSION; nicotine poisoning; and PROLONGED PREGNANCY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bronstein, M1
Deutsch, M1

Other Studies

1 other study available for albuterol and Oligohydramnios

ArticleYear
Early diagnosis of proximal femoral deficiency.
    Gynecologic and obstetric investigation, 1992, Volume: 34, Issue:4

    Topics: Adult; Albuterol; Asthma; Female; Femur; Fetal Diseases; Gestational Age; Humans; Maternal Age; Olig

1992